Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium StudyRichard H. Ko, Mignon L. Loh, Nita L. Seibel et al.|Journal of Clinical Oncology|2009Cited by 276
Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory NeuroblastomaSteven G. DuBois, Araz Marachelian, Yaël P. Mossé et al.|Clinical Cancer Research|2018Cited by 88
Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in OncologyRochelle Bagatell, Lisa Hang, Julie R. Park et al.|Journal of the National Comprehensive Cancer Network|2024Cited by 47